Universal Survival Curve and Single Fraction Equivalent Dose: Useful Tools in Understanding Potency of Ablative Radiotherapy: In Regard to Parks et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852)

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 5, 2008, Pages 1620-

  Tomé, Wolfgang A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL SURVIVAL; HUMAN; LETTER; MATHEMATICAL MODEL; MICROSCOPY; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT FAILURE; TUMOR VOLUME;

AGE FACTORS; AGED; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 2; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SURVIVAL ANALYSIS;

EID: 56349107442     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.08.032     Document Type: Letter

References (4)

1. Barendsen G.W. Responses of cultured cells, tumours, and normal tissues to radiations of different linear energy transfer. In: Ebert M., and Howard A. (Eds). Current topics in radiation research Vol. IV (1968), John Wiley & Sons, New York 293-356
2. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 (2003) 1946-1955
3. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 63 (2005) 1010-1015
4. Timmerman R.D., Park C., and Kavanagh B.D. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer. J Thorac Oncol 2 (2007) S101-S112